280 related articles for article (PubMed ID: 19615447)
1. Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors.
Izsvák Z; Chuah MK; Vandendriessche T; Ivics Z
Methods; 2009 Nov; 49(3):287-97. PubMed ID: 19615447
[TBL] [Abstract][Full Text] [Related]
2. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon.
Hollis RP; Nightingale SJ; Wang X; Pepper KA; Yu XJ; Barsky L; Crooks GM; Kohn DB
Exp Hematol; 2006 Oct; 34(10):1333-43. PubMed ID: 16982326
[TBL] [Abstract][Full Text] [Related]
3. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
4. Hyperactive transposase mutants of the Sleeping Beauty transposon.
Baus J; Liu L; Heggestad AD; Sanz S; Fletcher BS
Mol Ther; 2005 Dec; 12(6):1148-56. PubMed ID: 16150650
[TBL] [Abstract][Full Text] [Related]
5. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression.
Score PR; Belur LR; Frandsen JL; Geurts JL; Yamaguchi T; Somia NV; Hackett PB; Largaespada DA; McIvor RS
Mol Ther; 2006 Mar; 13(3):617-24. PubMed ID: 16356773
[TBL] [Abstract][Full Text] [Related]
6. Nonviral gene delivery with the sleeping beauty transposon system.
Ivics Z; Izsvák Z
Hum Gene Ther; 2011 Sep; 22(9):1043-51. PubMed ID: 21867398
[TBL] [Abstract][Full Text] [Related]
7. Rodent transgenesis mediated by a novel hyperactive Sleeping Beauty transposon system.
Mátés L
Methods Mol Biol; 2011; 738():87-99. PubMed ID: 21431721
[TBL] [Abstract][Full Text] [Related]
8. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.
Izsvák Z; Ivics Z; Plasterk RH
J Mol Biol; 2000 Sep; 302(1):93-102. PubMed ID: 10964563
[TBL] [Abstract][Full Text] [Related]
9. DNA transposons for modification of human primary T lymphocytes.
Huang X; Wilber A; McIvor RS; Zhou X
Methods Mol Biol; 2009; 506():115-26. PubMed ID: 19110623
[TBL] [Abstract][Full Text] [Related]
10. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
[TBL] [Abstract][Full Text] [Related]
11. Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors.
Holstein M; Mesa-Nuñez C; Miskey C; Almarza E; Poletti V; Schmeer M; Grueso E; Ordóñez Flores JC; Kobelt D; Walther W; Aneja MK; Geiger J; Bonig HB; Izsvák Z; Schleef M; Rudolph C; Mavilio F; Bueren JA; Guenechea G; Ivics Z
Mol Ther; 2018 Apr; 26(4):1137-1153. PubMed ID: 29503198
[TBL] [Abstract][Full Text] [Related]
12. Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.
Orbán TI; Apáti A; Németh A; Varga N; Krizsik V; Schamberger A; Szebényi K; Erdei Z; Várady G; Karászi E; Homolya L; Német K; Gócza E; Miskey C; Mátés L; Ivics Z; Izsvák Z; Sarkadi B
Stem Cells; 2009 May; 27(5):1077-87. PubMed ID: 19415778
[TBL] [Abstract][Full Text] [Related]
13. Construction and Quantitative Evaluation of a Tissue-Specific Sleeping Beauty by EDL2-Specific Transposase Expression in Esophageal Squamous Carcinoma Cell Line KYSE-30.
Mahmoudian RA; Fathi F; Farshchian M; Abbaszadegan MR
Mol Biotechnol; 2023 Mar; 65(3):350-360. PubMed ID: 35474410
[TBL] [Abstract][Full Text] [Related]
14. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.
Yant SR; Meuse L; Chiu W; Ivics Z; Izsvak Z; Kay MA
Nat Genet; 2000 May; 25(1):35-41. PubMed ID: 10802653
[TBL] [Abstract][Full Text] [Related]
15. Lung-directed gene therapy in mice using the nonviral Sleeping Beauty transposon system.
Belur LR; Podetz-Pedersen K; Frandsen J; McIvor RS
Nat Protoc; 2007; 2(12):3146-52. PubMed ID: 18079714
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in transposon-mediated gene therapy.
Di Matteo M; Belay E; Chuah MK; Vandendriessche T
Expert Opin Biol Ther; 2012 Jul; 12(7):841-58. PubMed ID: 22679910
[TBL] [Abstract][Full Text] [Related]
17. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo.
Yant SR; Ehrhardt A; Mikkelsen JG; Meuse L; Pham T; Kay MA
Nat Biotechnol; 2002 Oct; 20(10):999-1005. PubMed ID: 12244327
[TBL] [Abstract][Full Text] [Related]
18. Liver-directed gene therapy using the sleeping beauty transposon system.
Belur LR; McIvor RS; Wilber A
Methods Mol Biol; 2008; 434():267-76. PubMed ID: 18470650
[TBL] [Abstract][Full Text] [Related]
19. The Sleeping Beauty transposon toolbox.
Ammar I; Izsvák Z; Ivics Z
Methods Mol Biol; 2012; 859():229-40. PubMed ID: 22367875
[TBL] [Abstract][Full Text] [Related]
20. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
